FEBUXOSTAT
Febuxostat is a xanthine oxidase inhibitor lowering uric acid in gout. Side effects include rash, liver dysfunction, and increased cardiovascular risk. Only GMP materials will be supplied, logistics all according to GDP.
About MedicaPharma
MedicaPharma distributes high-quality active pharmaceutical ingredients (APIs) to hospitals, commercial (compounding) pharmacies, research institutes, and universities worldwide.
Network of over +400 GMP API producers
Let us handle your sourcing / supply activities. Highly experienced in sourcing specialty raw pharmaceutical ingredients from niche GMP manufacturers around the world.
Why Choose MedicaPharma
Niche API specialist - Pro-active supply partner - High service level - Global network - Logistics according to GDP regulations
Product Description
Mechanism of Action
Febuxostat is a selective nonpurine inhibitor of xanthine oxidase (XO). It blocks the conversion of hypoxanthine and xanthine into uric acid, lowering serum urate levels. It binds both molybdenumpterin and flavin adenine dinucleotide sites of XO.
Benefits and Advantages
Used in purinemetabolism research, gout pathophysiology modelling, XOinhibition assays, and oxidative stress mechanism studies.
Side Effects and Risks
Risks include hepatic dysfunction, cardiovascular events, rash and rare severe hypersensitivity. Handle with xanthineoxidase inhibitor precautions.
Only GMP materials will be supplied, logistics all according to GDP.
Datasheet
| Molecular Formula | C16H16N2O3S |
|---|---|
| Molecular Weight | 316.4 g/mol |
| CAS Number | 144060-53-7 |
| Storage Condition | COMPRESSED GASES MAY BE STORED IN THE OPEN ONLY IF THEY ARE ADEQUATELY PROTECTED FROM THE WEATHER & DIRECT SUNLIGHT. STORAGE AREAS SHOULD BE LOCATED AT A SAFE DISTANCE FROM OCCUPIED PREMISES & NEIGHBORING DWELLINGS. /GASES & AIR, COMPRESSED/ |
| Solubility | <1 mg/mL |
| Purity | Purity information is available upon request (COA). |
| Synonym | Febuxostat; 144060-53-7; Adenuric; Uloric; TMX-67 |
| IUPAC/Chemical Name | 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid |
| InChl Key | BQSJTQLCZDPROO-UHFFFAOYSA-N |
| InChl Code | InChI=1S/C16H16N2O3S/c1-9(2)8-21-13-5-4-11(6-12(13)7-17)15-18-10(3)14(22-15)16(19)20/h4-6,9H,8H2,1-3H3,(H,19,20) |
| References |
3D Conformer.
(Click, turn or enlarge)
Download our GMP API Product List.
MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.


